For millions of parents worldwide, standard milk formula serves as an important nutritional option when breastfeeding is not possible, insufficient, or supplemented. While it appears as a simple powdered product on retail shelves, the industry behind it represents one of the largest segments of infant nutrition globally.
The market combines science, regulation, healthcare, manufacturing, and consumer trust, making it one of the most closely monitored food categories worldwide.
What is Standard Milk Formula?
Standard milk formula is an infant formula primarily made from cow’s milk that has been modified to resemble the nutritional composition of breast milk.
It contains proteins, carbohydrates, fats, vitamins, minerals, DHA, ARA, iron, and other nutrients required for infant growth and development.
Unlike specialty formulas designed for allergies, lactose intolerance, or medical conditions, standard milk formula is intended for healthy infants and represents the largest segment of the infant nutrition industry.
Market Size at a Glance
The global standard milk formula market was valued at approximately USD 29 billion in 2025 and is projected to reach USD 49.2 billion by 2034, growing at a CAGR of around 6%.
The broader infant formula market is significantly larger, with demand supported by:
- Rising urbanization
- Increasing number of working mothers
- Higher disposable income
- Growing awareness of infant nutrition
- Expansion of e-commerce channels
Asia-Pacific remains the largest consumer region globally.
Simple Market Snapshot
| Metric | Value |
|---|---|
| Global Standard Milk Formula Market (2025) | USD 29 Billion |
| Forecast Market (2034) | USD 49.2 Billion |
| Expected CAGR | 6.0% |
| Largest Region | Asia-Pacific |
| Leading Company | Nestlé |
| Top 5 Players Share | 58.2% |
| Dominant Product Form | Powder Formula |
Why Asia-Pacific Dominates the Market
Asia-Pacific is the powerhouse of the standard milk formula industry.
The region accounted for nearly 69% of global infant formula revenues in 2025, valued at more than USD 60 billion. China remains the largest consumer, while India is emerging as one of the fastest-growing markets.
Several factors support growth:
- Large birth population
- Rapid urbanization
- Rising middle-class spending
- Expansion of organized retail
- Growing participation of women in the workforce
India alone is expected to generate approximately USD 2.41 billion in infant formula revenue during 2026.
Regional Market Share
| Region | Market Share |
|---|---|
| Asia-Pacific | 44%–69% |
| North America | 21%–24% |
| Europe | 19% |
| Middle East & Africa | 13% |
Market Segmentation
By Product Type
- Standard Formula
- Follow-on Formula
- Growing-up Milk
- Specialty Formula
By Source
- Cow Milk-Based Formula
- Soy Formula
- Goat Milk Formula
- Hydrolyzed Formula
- Organic Formula
By Form
- Powder Formula
- Liquid Concentrate
- Ready-to-Feed Formula
By Distribution Channel
- Pharmacies
- Supermarkets
- Hypermarkets
- Specialty Stores
- Online Platforms
Powder formula continues to dominate because of affordability, longer shelf life, and easier transportation.
Leading Companies and Their Market Position
Nestlé
Nestlé is the global leader in standard milk formula through brands such as NAN, Lactogen, Nestogen, Nido, and Gerber.
The company held approximately 23.7% market share in 2025, making it the largest player worldwide.
Nestlé generated over CHF 91 billion in total revenue during 2025, although infant nutrition represents only part of its portfolio. Recent investments have focused on product innovation and strengthening operations in China.
Danone
Danone owns major infant nutrition brands including Aptamil and Nutrilon.
The company controlled approximately 16.8% of global standard milk formula revenue in 2025.
Danone reported:
- Q1 2026 Revenue: €6.7 billion
- Q2 2025 Operating Income: €1.81 billion
- Strong growth from China’s infant formula market
The company continues investing heavily in specialized nutrition and medical nutrition products.
Abbott Laboratories
Abbott is a major global player through its Similac brand.
The company holds approximately 9.6% market share in the standard milk formula segment.
Abbott remains particularly strong in North America and hospital-based infant nutrition channels.
Reckitt Benckiser (Mead Johnson Nutrition)
Through Enfamil, Reckitt continues to be one of the world’s largest infant formula suppliers.
The company benefits from strong pediatrician recommendations and hospital partnerships.
FrieslandCampina
Known for Friso products, FrieslandCampina has built a strong presence across Asia, especially China and Southeast Asia.
Government Regulations Driving the Industry
Infant formula is one of the most heavily regulated food categories worldwide.
Government agencies such as:
- World Health Organization
- U.S. Food and Drug Administration
- European Food Safety Authority
- Food Safety and Standards Authority of India
require strict standards for nutrient composition, safety testing, manufacturing quality, labeling, and marketing practices.
The UK Competition and Markets Authority also completed a major review of the infant formula industry in 2025 due to pricing and competition concerns.
Future Outlook
The future of the standard milk formula market is shifting toward:
- Premium nutrition products
- Organic formulas
- A2 milk formulations
- Gut-health ingredients
- DHA and probiotic enrichment
- Sustainable packaging
- Digital retail and subscription models
Although declining birth rates in some developed countries create challenges, growth in India, Southeast Asia, Africa, and premium nutrition categories is expected to keep the market expanding through the next decade.
Key Takeaway
Standard milk formula remains the backbone of the global infant nutrition industry. With a market exceeding USD 28 billion, dominated by companies such as Nestlé, Danone, Abbott, Reckitt, and FrieslandCampina, the sector continues to attract investment due to rising nutrition awareness, premiumization trends, and strong demand across Asia-Pacific. The combination of strict regulation, scientific innovation, and consumer trust will continue shaping the industry’s next phase of growth.
Get Easy Assess
Access our exclusive, data-rich dashboard dedicated to the life science industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium